Skip to main content

Advertisement

Table 2 Baseline characteristics and first 3-month BWW utilization among extension trial participants

From: Extending access to a web-based mental health intervention: who wants more, what happens to use over time, and is it helpful? Results of a concealed, randomized controlled extension study

Baseline Variable Extension Group
n = 55
Discontinuation Group
n = 57
Recruitment site, n(%)a
 A (General Hospital) 27 (47) 25 (45)
 B (Provincial Mental Health Facility) 16 (28) 17 (31)
 C (Ambulatory Care Hospital) 14 (25) 13 (24)
RAS-r total score, mean (SD) 82.4 (13.9) 83.8 (12.7)
PHQ-9 total score, mean (SD) 13.3 (6.6) 10.9 (5.7)
GAD-7 total score, mean (SD) 9.9 (5.0) 9.6 (5.4)
EQ VAS, mean (SD) 54.4 (24.3) 60.0 (19.6)
CIQ total score, mean (SD) 13.7 (4.7) 13.7 (4.4)
Total number of BWW log-ins in first 3 months, median (Q1,Q3) 7 (2, 22) 7 (2, 18)
Age, mean (SD) 40.6 (13.1) 43.0 (12.2)
Gender, n(%)
 Male 9 (16) 18 (32)
 Female 46 (84) 38 (67)
 Transgendered 0 (0) 1 (2)
Ethnicity, n(%)
 White 48 (87) 44 (77)
 Non-white 7 (13) 13 (23)
Relationship Status, n(%)
 In a relationship 28 (51) 35 (61)
 Not in a relationship 27 (49) 22 (39)
Employment Status, n(%)
 Full-time (including. Homemaker with young children) 14 (25) 26 (46)
 Part-time/volunteer/homemaker without young children 11 (20) 6 (11)
 Not working 29 (53) 25 (44)
 Missing 1 (< 1) 0 (0)
Household income [$CAD], n(%)
  < $35 K 26 (47) 19 (33)
 $35 K - $50 K 4 (7) 7 (12)
 $50 K - $80 K 7 (13) 11 (19)
  > $80 K 12 (22) 12 (21)
 Missing 6 (11) 8 (14)
Age [y] first experienced mental health problems, median (Q1,Q3) 14 (8, 20) 16 (13, 29)
Age [y] first sought help, median (Q1,Q3) 19 (15, 27) 25 (18, 37)
Taking psychotropic medication, n(%) 48 (87) 40 (70)
  1. Baseline represents the time point when extended access was offered. Percentages are column percentages and may not add exactly to 100.0% due to rounding
  2. aRandomisation was stratified by recruitment site
  3. SD standard deviation, Q1 first quartile, Q3 third quartile, CAD Canadian RAS-r: Recovery Assessment Scale – revised, PHQ-9 Patient Health Questionnaire – 9 item, GAD-7 Generalized Anxiety Disorder Questionnaire – 7 item, EQ-VAS EuroQOL Visual Analog Scale, CIQ Community Integration Questionnaire